Skip to main navigation Skip to search Skip to main content

An MRF-based discrete optimization framework for combined DCE-MRI motion correction and pharmacokinetic parameter estimation

  • Monica Enescu
  • , Mattias P. Heinrich
  • , Esme Hill
  • , Ricky Sharma
  • , Michael A. Chappell
  • , Julia A. Schnabel
  • University of Oxford
  • University of Lüebeck

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Dynamic contrast-enhanced MRI (DCE-MRI) images are increasingly used for assessing cancer treatment outcome. These time sequences are typically affected by motion, which causes significant errors in tracer kinetic model analysis. Current intra-sequence registration methods for contrast enhanced data either assume restricted transformations (e.g. translation) or employ continuous optimization, which is prone to local optima. In this work, we propose a new approach to DCE-MRI intra-sequence registration and pharmacokinetic modelling, which is formulated in an MRF optimization framework. The complete 4D graph corresponding to a DCE-MRI sequence is reduced to a concatenation of minimum spanning trees, which can be optimized more efficiently. To address the changes due to contrast, a data cost function which incorporates pharmacokinetic modelling information is formulated. The advantages of this method are demonstrated on 8 DCE-MRI image sequences of patients with advanced rectal tumours, presenting mild to severe motion.

Original languageEnglish
Pages (from-to)73-84
Number of pages12
JournalLecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)
Volume8677
DOIs
StatePublished - 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'An MRF-based discrete optimization framework for combined DCE-MRI motion correction and pharmacokinetic parameter estimation'. Together they form a unique fingerprint.

Cite this